Evidence map›Paper›PMID 38904640›Full record

ArticleInvestigative ophthalmology & visual science2024

Conditional Knockouts of Interphotoreceptor Retinoid Binding Protein Suggest Two Independent Mechanisms for Retinal Degeneration and Myopia.

Tatiana E Getz, Micah A Chrenek, Jack T Papania, Debresha A Shelton, Shanu Markand, P Michael Iuvone, Zbynek Kozmik, Jeffrey H Boatright, John M Nickerson

Abstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tatiana E GetzEmory University, Department of Ophthalmology, Atlanta, Georgia, United States.
Micah A ChrenekEmory University, Department of Ophthalmology, Atlanta, Georgia, United States.
Jack T PapaniaEmory University, Department of Ophthalmology, Atlanta, Georgia, United States.
Debresha A SheltonEmory University, Department of Ophthalmology, Atlanta, Georgia, United States.
Shanu MarkandKirksville College of Osteopathic Medicine, A.T. Still University, Kirksville, Missouri, United States.
P Michael IuvoneEmory University, Department of Ophthalmology, Atlanta, Georgia, United States.
Zbynek KozmikInstitute of Molecular Genetics of the ASCR, Prague, Czech Republic.
Jeffrey H BoatrightEmory University, Department of Ophthalmology, Atlanta, Georgia, United States.
John M NickersonEmory University, Department of Ophthalmology, Atlanta, Georgia, United States.

Funding

Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
P30-Core Grant for Vision Research Core CP30EY006360 · NEI · EMORY UNIVERSITY · PI GROSSNIKLAUS, HANS E. · 1986 to 2025
$15.3M
Neuromodulators and Circadian Clocks: Roles in Retinal Function and DysfunctionR01EY004864 · NEI · EMORY UNIVERSITY · PI IUVONE, P MICHAEL · 1985 to 2018
$7.0M
VIsion Science Training in AtlantaT32EY007092 · NEI · EMORY UNIVERSITY · PI Machelle T. Pardue · 1985 to 2026
$4.6M
Ocular Growth, Emmetropia, and Interphotoreceptor Retinoid-Binding Protein (IRBP)R01EY021592 · NEI · EMORY UNIVERSITY · PI BOATRIGHT, JEFFREY H, IUVONE, P MICHAEL · 2013 to 2021
$3.3M
The RPE and Recovery of the Blood Retina BarrierR01EY028450 · NEI · EMORY UNIVERSITY · PI BOATRIGHT, JEFFREY H, GROSSNIKLAUS, HANS E. · 2018 to 2022
$2.4M
Exercise-induced Retinal NeuroprotectionR01EY028859 · NEI · EMORY UNIVERSITY · PI BOATRIGHT, JEFFREY H, PARDUE, MACHELLE T. · 2018 to 2021
$2.0M
Deciphering the Usher I protein interactome using a genetic approachR01DC009246 · NIDCD · CASE WESTERN RESERVE UNIVERSITY · PI ZHENG, QING Y · 2009 to 2013
$1.6M
A TrkB Activator for Treatment of GlaucomaI01RX002806 · VA · VETERANS HEALTH ADMINISTRATION · PI BOATRIGHT, JEFFREY H · 2019 to 2024
–
Bridging animal and human models of exercise-induced visual rehabilitationI21RX001924 · VA · VETERANS HEALTH ADMINISTRATION · PI BOATRIGHT, JEFFREY H · 2015 to 2017
–
NCATS NIH HHS UL1 TR000454NEI NIH HHS P30 EY006360NEI NIH HHS R01 EY004864NEI NIH HHS R01 EY021592NEI NIH HHS R01 EY028450NEI NIH HHS R01 EY028859NEI NIH HHS T32 EY007092NIDCD NIH HHS R01 DC009246RRD VA I01 RX002806RRD VA I21 RX001924
6 · The paper itself

Abstract

Purpose: Interphotoreceptor retinoid-binding protein's (IRBP) role in eye growth and its involvement in cell homeostasis remain poorly understood. One hypothesis proposes early conditional deletion of the IRBP gene could lead to a myopic response with retinal degeneration, whereas late conditional deletion (after eye size is determined) could cause retinal degeneration without myopia. Here, we sought to understand if prior myopia was required for subsequent retinal degeneration in the absence of IRBP. This study investigates if any cell type or developmental stage is more important in myopia or retinal degeneration. Methods: IBRPfl/fl mice were bred with 5 Cre-driver lines: HRGP-Cre, Chx10-Cre, Rho-iCre75, HRGP-Cre Rho-iCre75, and Rx-Cre. Mice were analyzed for IRBP gene expression through digital droplet PCR (ddPCR). Young adult (P30) mice were tested for retinal degeneration and morphology using spectral-domain optical coherence tomography (SD-OCT) and hematoxylin and eosin (H&E) staining. Function was analyzed using electroretinograms (ERGs). Eye sizes and axial lengths were compared through external eye measurements and whole eye biometry. Results: Across all outcome measures, when bred to IRBPfl/fl, HRGP-Cre and Chx10-Cre lines showed no differences from IRBPfl/fl alone. With the Rho-iCre75 line, small but significant reductions were seen in retinal thickness with SD-OCT imaging and postmortem H&E staining without increased axial length. Both the HRGP-Cre+Rho-iCre75 and the Rx-Cre lines showed significant decreases in retinal thickness and outer nuclear layer cell counts. Using external eye measurements and SD-OCT imaging, both lines showed an increase in eye size. Finally, function in both lines was roughly halved across scotopic, photopic, and flicker ERGs. Conclusions: Our studies support hypotheses that for both eye size determination and retinal homeostasis, there are two critical timing windows when IRBP must be expressed in rods or cones to prevent myopia (P7-P12) and degeneration (P21 and later). The rod-specific IRBP knockout (Rho-iCre75) showed significant retinal functional losses without myopia, indicating that the two phenotypes are independent. IRBP is needed for early development of photoreceptors and eye size, whereas Rho-iCre75 IRBPfl/fl knockout results in retinal degeneration without myopia.

Indexed as

Disease Models, AnimalElectroretinographyEye ProteinsMice, KnockoutMyopiaRetinal DegenerationRetinol-Binding ProteinsTomography, Optical CoherenceAnimalsFemaleMaleMiceMice, Inbred C57BLRetinaRetinol-Binding Proteins, InterstitialEye ProteinsRetinol-Binding ProteinsRetinol-Binding Proteins, Interstitial

Identifiers

PMID38904640
PMCPMC11193143

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.